# US Kidney Stones Market > US Kidney Stones Market Research Report By Type (Calcium Oxalate Stones, Uric Acid, Struvite Kidney Stones, Cystine Stones, Calcium Phosphate Stones), By Treatment Type (Medications, Extracorporeal Shock Wave Lithotripsy, Ureteroscopy, Percutaneous Nephrolithotomy) and By Diagnosis (Ultrasound, Intravenous Pyelography, CT scan, X-Ray, Others) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 4.82% - **2024:** $ 567 Million - **2025:** $ 594.33 Million - **2035:** $ 951.65 Million - **Key Players:** Boston Scientific (US), Medtronic (US), Johnson & Johnson (US), C.R. Bard (US), Cook Medical (US), Olympus Corporation (JP), Stryker Corporation (US), Terumo Corporation (JP), Karl Storz (DE) **Report ID:** MRFR/LS/51541-HCR · **Pages:** 200 · **Author:** Nidhi Mandole & Rahul Gotadki · **Last Updated:** February 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/us-kidney-stones-market-53302 --- ## Market Summary ## US Kidney Stones Market Overview As per MRFR analysis, the US Kidney Stones Market Size was estimated at 546 (USD Million) in 2023.The US Kidney Stones Market Industry is expected to grow from 600(USD Million) in 2024 to 1,100 (USD Million) by 2035. The US Kidney Stones Market CAGR (growth rate) is expected to be around 5.665% during the forecast period (2025 - 2035). ### Key US Kidney Stones Market Trends Highlighted The US Kidney Stones Market is undergoing some important shifts due to the rising prevalence of kidney stones, particularly in adults. This increase is attributed to a number of reasons, including changes in diet, high obesity rates, and other lifestyle factors. The use of advanced imaging methods and minimally invasive surgical techniques has additionally changed the treatment paradigm, allowing for quicker recovery and shorter hospital stays. This technological change is a major driver of the market, as it boosts recovery outcomes and patient satisfaction. This shift attracts more providers to these solutions. There are amazing gaps to be filled in the US Market especially in the form of preventive measures and personal health management technologies. Nutrition counselling combined with hydration services will likely grow in popularity as proactively caring for one’s health becomes more prioritized. Also, the incorporation of telehealth services offers a novel opportunity to improve education and patient participation around the prevention and management of kidney stones, in accordance with the increase of the digital health trend in the United States healthcare system. Recently, there has been initiative shift towards initiative-taking healthcare primarily from healthcare and public health institutions. More campaigns promoting knowledge related to kidney stones, their underlying factors, and management techniques are emerging. Alongside this, the promotion of healthy changes and living also significantly homes in on Americans. Therefore, this provides an additional opportunity for a broad range of stakeholders within the healthcare system to devise initiatives aimed at reducing the risk factors driving the prevalence of kidney stones for better population health. ## US Kidney Stones Market Drivers ### Increasing Incidence of Kidney Stones in the United States The US [Kidney Stones Market](../../../reports/us-kidney-stones-market-53302) Industry is witnessing significant growth due to the increasing incidence of kidney stones among the population. According to the National Institute of Diabetes and Digestive and Kidney Diseases, approximately 1 in 10 Americans will develop a kidney stone in their lifetime. This statistic highlights a growing health concern that can drive the market forward as more individuals seek effective treatments and preventive measures. In addition, data from the American Urological Association indicates that the prevalence of kidney stones has nearly doubled in the last 30 years, particularly affecting individuals aged 30 to 60. This demographic shift presents a growing market opportunity for healthcare providers and pharmaceutical companies focused on developing innovative treatments for kidney stones. The accelerating rates of obesity and metabolic syndrome in the US population, which contribute to the formation of kidney stones, further emphasize the potential for market growth in this sector. With increased awareness and advancements in technology, the demand for diagnostic and treatment options related to kidney stones is anticipated to surge significantly impacting the US Kidney Stones Market Industry. ### Advancements in Medical Technology for Kidney Stones Treatment The US Kidney Stones Market Industry is experiencing robust growth due to ongoing advancements in medical technology, particularly in diagnostic and treatment options. The introduction of minimally invasive procedures such as ureteroscopy and shock wave lithotripsy has revolutionized the treatment of kidney stones, increasing patient comfort and recovery times. The American Urological Association emphasizes that these innovative procedures lead to higher success rates and lower complication rates, which are critical factors driving adoption among both patients and healthcare providers. Additionally, technological advancements in imaging techniques such as CT scans and ultrasounds enable earlier diagnosis and intervention, further enhancing treatment outcomes. As a result, leading medical manufacturers and organizations are investing in Research and Development (R&D) to improve these technologies, solidifying growth prospects within the market. ### Rising Awareness about Kidney Health and Preventive Care Another significant driver contributing to the growth of the US Kidney Stones Market Industry is the rising awareness among the population regarding kidney health and preventive care. Public health campaigns led by organizations like the National Kidney Foundation are emphasizing the importance of maintaining hydration and dietary modifications to prevent kidney stone formation. Such awareness initiatives have resulted in increased screenings and preventive strategies among high-risk populations, particularly those with a history of kidney stones. According to the Centers for Disease Control and Prevention, the number of individuals receiving preventive care services has risen, reflecting a shift towards proactive health management. This growing inclination toward preventive measures is likely to bolster the demand for dietary supplements, medications, and educational resources associated with kidney stones, propelling market expansion. ## US Kidney Stones Market Segment Insights ### Kidney Stones Market Type Insights The Type segment of the US Kidney Stones Market encompasses a variety of kidney stone compositions, each with unique clinical implications and treatment approaches. Among these, Calcium Oxalate Stones represent the most prevalent form, often associated with dietary factors and dehydration, which are significant health concerns in the United States, particularly due to modern lifestyle choices. The presence of Uric Acid stones is of particular interest, primarily linked to dietary habits, metabolic conditions, and obesity, highlighting a growing need for public awareness regarding nutrition and its direct impact on kidney stone formation. Struvite Kidney Stones, often resultant from urinary tract infections, indicate a different health pathway, emphasizing the importance of managing urinary health to prevent such occurrences. Cystine Stones, while less common, are crucial due to their genetic predispositions, requiring targeted interventions and personalized treatment plans for affected patients. Additionally, Calcium Phosphate Stones, which are usually associated with metabolic disorders, underscore the importance of early diagnosis and proper management of underlying health conditions to mitigate the risk of stone formation. These various types of kidney stones reflect significant segments in the US Kidney Stones Market, each demonstrating a unique prevalence, associated health risks, and treatment considerations that influence both healthcare practices and patient management strategies. Awareness and education regarding the different types of kidney stones can drive market growth and improve patient outcomes, paving the way for innovative approaches in treatment and prevention in the future. ### Kidney Stones Market Treatment Type Insights The Treatment Type segment of the US Kidney Stones Market plays a crucial role in addressing the needs of patients experiencing kidney stones, which are a prevalent health issue in the United States. Various treatment options, such as Medications, Extracorporeal Shock Wave Lithotripsy, Ureteroscopy, and Percutaneous Nephrolithotomy, offer diverse approaches tailored to the severity and characteristics of the condition. Medications often serve as an initial management strategy to alleviate pain and facilitate stone passage. Extracorporeal Shock Wave Lithotripsy is prominent for its non-invasive nature, efficiently targeting stones with minimal recovery time, thus catering to a large population seeking less invasive treatment options. Ureteroscopy enables direct visualization and removal of stones, providing physicians with operational flexibility while ensuring patient safety. Percutaneous Nephrolithotomy is noteworthy for its effectiveness in managing larger stones, where other treatments may fall short. The ongoing advancements and effectiveness of these treatment strategies contribute significantly to the overall US Kidney Stones Market revenue, aligning with a growing demand for efficient and patient-centric solutions in urological care. The increasing prevalence of kidney stones in the US underscores the importance of these treatment types in addressing public health challenges and enhancing patient outcomes. ### Kidney Stones Market Diagnosis Insights The Diagnosis segment of the US Kidney Stones Market is vital in the overall management and treatment of kidney stones, showcasing significant growth driven by advancements in medical technology and increasing awareness among patients. Different diagnostic methods, including Ultrasound, Intravenous Pyelography, CT scan, and X-Ray, collectively contribute to accurate detection and assessment of kidney stones, allowing for timely intervention. Ultrasound is noted for its non-invasive nature and reduced radiation exposure, making it popular among physicians and patients. The Intravenous Pyelography method is traditionally significant for its detailed visualization of urinary tract structures, enhancing diagnosis accuracy. CT scans are highly regarded for their precision in detecting even small stones, thus dominating the diagnostic landscape. X-Ray still plays a role but is less emphasized in complex cases. The US Kidney Stones Market statistics highlight that the rising prevalence of kidney stones, coupled with an aging population and lifestyle changes, is propelling demand for innovative diagnostic solutions that not only improve patient outcomes but also streamline healthcare processes. As the healthcare industry continues to evolve, opportunities for enhancing diagnostic efficiency and patient care in the US Kidney Stones Market remain abundant. ## US Kidney Stones Market Key Players and Competitive Insights: The US Kidney Stones Market has seen significant growth driven by the increasing incidence of kidney stones, technological advancements in the diagnostic and therapeutic procedures, and a rising awareness of preventive health measures. The competitive landscape is characterized by a diverse array of players ranging from established multinational corporations to specialized niche companies. This market is influenced by various factors including regulatory approvals, access to cutting-edge technologies, and collaborative ventures. As healthcare continues to evolve, companies are prioritizing innovations that enhance patient outcomes while also focusing on cost-efficiency. The growing prevalence of kidney stones has prompted extensive research and development efforts aimed at improving treatment protocols and reducing the need for invasive procedures. As a result, competition is intensifying, with firms striving to establish their market presence through strategic partnerships and acquisitions, broadening their product portfolios, and enhancing their brand visibility. Olympus Corporation maintains a robust presence in the US Kidney Stones Market through its advanced medical technology and a strong commitment to innovation. Known for their high-quality endoscopic equipment, Olympus has established a reputation for offering effective solutions for the diagnosis and treatment of kidney stones, such as ureteroscopy and laser lithotripsy systems. Its strengths in the market lie in its comprehensive range of products, which cater to various clinical needs, ensuring that healthcare providers have access to the latest technology for patient care. Moreover, Olympus benefits from significant investments in research and development, enabling it to stay ahead of competitors in delivering cutting-edge solutions. The company's focus on user-friendly and reliable products has garnered strong clinician trust, further solidifying Olympus's competitive position in the US market. Coloplast has also made a notable impact in the US Kidney Stones Market with its innovative offerings designed for both prevention and treatment of kidney stones. The company specializes in various medical devices and services, including catheter solutions and drainage systems, which are crucial for managing patients with urinary tract conditions. Coloplast's strengths lie in its commitment to patient-centric healthcare, providing educational resources and support services that improve patient outcomes. The company has focused on mergers and acquisitions that expand its product lines, allowing it to leverage synergies and enhance its operational efficiency within the region. By forging strategic alliances and maintaining high-quality standards, Coloplast has successfully positioned itself within the competitive landscape of the US Kidney Stones Market, catering to healthcare professionals with effective solutions tailored to meet the growing demands in kidney stone management. ### Key Companies in the US Kidney Stones Market Include: - Olympus Corporation - Coloplast - Allergan - Cook Medical - Karl Storz - Boston Scientific - Stryker - UroLift - Johnson & Johnson - Auris Health - [**Medtronic**](https://www.medtronic.com/en-ca/l/your-health/conditions/urinary-retention.html) - Varian Medical Systems - CooperSurgical - R. Bard - Teleflex ## US Kidney Stones Market Industry Developments The US Kidney Stones Market has seen significant developments recently, driven by advancements in technology and increasing prevalence of kidney stones. In September 2023, Olympus Corporation announced the launch of a new endoscopic device designed for better management of kidney stones, showcasing innovation in minimally invasive treatments. Meanwhile, Coloplast is focusing on expanding its product line to cater to the rising demand for less invasive procedures, aligning with current patient preferences. In terms of mergers, in August 2023, Medtronic acquired Mazor Robotics, enhancing its capabilities in robotic-assisted surgery, which could benefit kidney stone treatment protocols. Additionally, Boston Scientific's recent partnership with UroLift in July 2023 aims to broaden access to urinary health solutions, indirectly impacting the kidney stones segment. The overall market has experienced a shift towards more technologically-driven solutions, with companies like Stryker and Johnson and Johnson enhancing their Research and Development efforts to provide state-of-the-art solutions for kidney stone management. Joslin Diabetes Center statistics show that the incidence of kidney stones continues to rise, influencing market demand and encouraging companies to innovate in treatment approaches. ## US Kidney Stones Market Segmentation Insights ### Kidney Stones Market Type Outlook - Calcium Oxalate Stones - Uric Acid - Struvite Kidney Stones - Cystine Stones - Calcium Phosphate Stones ### Kidney Stones Market Treatment Type Outlook - Medications - Extracorporeal Shock Wave Lithotripsy - Ureteroscopy - Percutaneous Nephrolithotomy ### Kidney Stones Market Diagnosis Outlook - Ultrasound - Intravenous Pyelography - CT scan - X-Ray - Others ## Market Drivers ### Rising Healthcare Expenditure The market is benefiting from the rising healthcare expenditure in the US. Increased spending on healthcare services, including preventive care and treatment options for kidney stones, is expected to drive market growth. In 2025, healthcare expenditure is projected to reach approximately $4 trillion, with a significant portion allocated to urology and nephrology services. This financial commitment indicates a growing recognition of the importance of addressing kidney health issues. As healthcare systems invest more in managing kidney stones, the market is likely to see enhanced access to treatment options and improved patient outcomes. ### Enhanced Diagnostic Techniques Advancements in diagnostic techniques are playing a crucial role in the kidney stones market. The introduction of non-invasive imaging technologies, such as ultrasound and CT scans, has improved the accuracy of kidney stone detection. These innovations allow for earlier diagnosis and more effective treatment planning, which is essential for patient outcomes. The market for diagnostic tools is projected to grow significantly, with estimates suggesting an increase of 6% in the next few years. As healthcare providers adopt these advanced diagnostic methods, the kidney stones market is likely to benefit from increased patient awareness and timely interventions. ### Growing Awareness of Kidney Health There is a notable increase in public awareness regarding kidney health, which is positively impacting the kidney stones market. Educational campaigns and initiatives aimed at promoting hydration and healthy dietary choices are becoming more prevalent. This heightened awareness is likely to lead to a reduction in the incidence of kidney stones, thereby influencing market dynamics. According to recent surveys, nearly 70% of individuals are now aware of the importance of maintaining kidney health. This trend may result in a shift towards preventive measures, ultimately affecting the demand for treatment options in the kidney stones market. ### Increasing Prevalence of Risk Factors The kidney stones market is experiencing growth due to the rising prevalence of risk factors associated with stone formation. Factors such as obesity, diabetes, and dietary habits contribute significantly to the incidence of kidney stones. In the US, studies indicate that approximately 10% of the population will experience a kidney stone at some point in their lives. This increasing prevalence of risk factors is likely to drive demand for treatment options and preventive measures within the kidney stones market. As healthcare providers focus on managing these risk factors, the market is expected to expand, with a projected growth rate of around 5% annually over the next few years. ### Innovations in Minimally Invasive Procedures Innovations in minimally invasive procedures are transforming the kidney stones market. Techniques such as ureteroscopy and percutaneous nephrolithotomy are gaining traction due to their effectiveness and reduced recovery times. These advancements are appealing to both patients and healthcare providers, as they offer less discomfort and quicker return to normal activities. The market for these procedures is expected to grow, with estimates suggesting an increase of 7% in the coming years. As more patients seek out these less invasive options, the kidney stones market is likely to expand, reflecting a shift in treatment preferences. ## Future Outlook The [Kidney Stones Market](https://www.marketresearchfuture.com/reports/kidney-stones-market-1745) is projected to grow at a 4.82% CAGR from 2025 to 2035, driven by advancements in treatment technologies and increasing prevalence of kidney stones. **New opportunities:** - Development of AI-driven diagnostic tools for early detection Expansion of telehealth services for remote patient monitoring Investment in minimally invasive surgical technologies for treatment By 2035, the kidney stones market is expected to achieve substantial growth and innovation. ## Segment Insights ### By Type: Calcium Oxalate Stones (Largest) vs. Uric Acid (Fastest-Growing) The US kidney stones market exhibits a notable distribution in the 'Type' segment, with Calcium Oxalate Stones representing the largest share. This segment accounts for a significant portion of cases due to lifestyle factors and dietary habits prevalent in the population. Uric Acid stones follow, appealing to a subset of patients with specific metabolic conditions. Meanwhile, Struvite, Cystine, and Calcium Phosphate stones hold smaller shares but remain critical for a comprehensive understanding of the market dynamics. Growth trends highlight an increasing prevalence of kidney stone cases, driven by dietary changes, obesity, and rising metabolic disorders. The Uric Acid segment is emerging as the fastest-growing area due to awareness about related health issues and innovations in treatment options. Enhanced preventive measures and lifestyle interventions are also contributing to the evolving landscape of the US kidney stones market. These trends underline the need for targeted research and tailored therapeutic strategies. Calcium Oxalate Stones (Dominant) vs. Uric Acid (Emerging) Calcium Oxalate Stones are recognized as the dominant type in the US kidney stones market, attributed to their association with common dietary factors such as high oxalate intake. This segment is characterized by its significant prevalence among different demographics, especially in middle-aged individuals. On the other hand, Uric Acid stones are emerging as a crucial focus area, particularly among patients with gout or metabolic syndrome. As dietary management and awareness increase, this segment is gaining traction. The characteristics of these stones demand varying treatment protocols, thus indicating a dynamic interplay within the market that physicians and healthcare providers must navigate effectively. ### By Treatment Type: Extracorporeal Shock Wave Lithotripsy (Largest) vs. Ureteroscopy (Fastest-Growing) In the US kidney stones market, the treatment type segment showcases a varied distribution among four key values: Medications, Extracorporeal Shock Wave Lithotripsy, Ureteroscopy, and Percutaneous Nephrolithotomy. Extracorporeal Shock Wave Lithotripsy currently holds the largest market share, indicating its established position among patients seeking non-invasive treatments. Ureteroscopy is gaining traction as a preferred option due to its minimally invasive nature, resulting in a significant share that is rapidly increasing, appealing to a growing demographic requiring urgent care solutions. Growth in the treatment type segment is driven by several factors. Increasing awareness regarding kidney stones treatment and advances in medical technologies are propelling the adoption of Extracorporeal Shock Wave Lithotripsy. Meanwhile, the rise in Ureteroscopy procedures is fueled by its effectiveness and lower recovery times compared to traditional methods. As more patients prioritize faster treatment and recovery, Ureteroscopy is emerging as a go-to choice, indicating a shift towards innovative and efficiency-focused approaches in the market. Medications (Dominant) vs. Percutaneous Nephrolithotomy (Emerging) Medications remain a dominant treatment type for patients dealing with kidney stones, primarily because they are often the first line of defense against pain and discomfort. They help in breaking down stones and alleviating symptoms, thus serving a broad segment of the population. On the other hand, Percutaneous Nephrolithotomy is emerging as a crucial intervention for larger stone removal, particularly in severe cases. Its adoption is increasing as patients prefer advanced techniques with reduced hospital stays. The balance between these treatment types reflects patient needs, with a significant tilt towards effective and less invasive solutions in the US kidney stones market. ### By Diagnosis: CT Scan (Largest) vs. Ultrasound (Fastest-Growing) In the US kidney stones market, the diagnosis segment is characterized by a variety of imaging techniques. CT Scan currently holds the largest market share due to its high accuracy and efficiency in diagnosing kidney stones, followed by Intravenous Pyelography and X-Ray. Ultrasound, while traditionally less dominant, is gaining traction due to its non-invasive nature and safety profile, particularly among patients who are sensitive to radiation exposure. Growth trends for the diagnosis segment are largely driven by advancements in imaging technology and an increasing awareness of kidney stone prevalence. The shift towards less invasive techniques like Ultrasound indicates an emerging preference among healthcare providers. Additionally, the aging population and lifestyle changes associated with urbanization are contributing to a higher incidence of kidney stones, further fueling this segment's growth. CT Scan (Dominant) vs. Ultrasound (Emerging) CT Scan is the dominant diagnostic tool in the US kidney stones market, renowned for its precision in identifying stone location, size, and composition. With advanced capabilities, it enables prompt treatment decisions, strengthening its position within the segment. In contrast, Ultrasound is emerging as a preferred method, especially for pregnant patients or those aiming to avoid radiation exposure. Its growing adoption reflects a shift towards patient-centered care, where safety and comfort are prioritized. Both techniques cater to specific patient needs, driving innovation and competition within the market as they each offer unique benefits. ## Competitive Benchmarking The market exhibits a dynamic competitive landscape characterized by innovation and strategic partnerships among key players. Major companies such as Boston Scientific (US), Medtronic (US), and Johnson & Johnson (US) are actively engaged in enhancing their product offerings and expanding their market presence. Boston Scientific (US) focuses on developing advanced minimally invasive technologies, which positions it favorably in a market increasingly leaning towards less invasive treatment options. Medtronic (US) emphasizes digital health solutions, integrating AI and data analytics into its product lines, thereby enhancing patient outcomes and operational efficiency. Johnson & Johnson (US) leverages its extensive research capabilities to innovate in surgical instruments and therapies, which collectively shapes a competitive environment that prioritizes technological advancement and patient-centric solutions.The business tactics employed by these companies reflect a concerted effort to optimize supply chains and localize manufacturing. The market structure appears moderately fragmented, with several players vying for market share while also collaborating through strategic alliances. This collective influence of key players fosters a competitive atmosphere where innovation and operational efficiency are paramount. In October Boston Scientific (US) announced the launch of a new laser lithotripsy system designed to enhance the fragmentation of kidney stones, which is expected to significantly improve patient recovery times. This strategic move underscores the company's commitment to innovation and its focus on addressing the evolving needs of healthcare providers and patients alike. The introduction of this technology may potentially strengthen Boston Scientific's market position by offering superior treatment options. In September Medtronic (US) unveiled a partnership with a leading telehealth provider to integrate remote monitoring capabilities into its kidney stone management solutions. This collaboration aims to enhance patient engagement and streamline treatment processes, reflecting a growing trend towards digital health solutions. By leveraging telehealth, Medtronic (US) positions itself at the forefront of a market increasingly reliant on technology to improve patient care. In August Johnson & Johnson (US) completed the acquisition of a startup specializing in AI-driven diagnostics for urological conditions, including kidney stones. This acquisition is likely to bolster Johnson & Johnson's capabilities in predictive analytics, enabling more personalized treatment plans. The strategic importance of this move lies in its potential to enhance the company's product portfolio and provide a competitive edge in a rapidly evolving market. As of November current trends in the kidney stones market indicate a pronounced shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, allowing companies to pool resources and expertise. Looking ahead, competitive differentiation is expected to evolve, with a marked transition from price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This shift may redefine market dynamics, compelling companies to prioritize research and development to maintain a competitive edge. ## Recent News & Developments The US Kidney Stones Market has seen significant developments recently, driven by advancements in technology and increasing prevalence of kidney stones. In September 2023, Olympus Corporation announced the launch of a new endoscopic device designed for better management of kidney stones, showcasing innovation in minimally invasive treatments. Meanwhile, Coloplast is focusing on expanding its product line to cater to the rising demand for less invasive procedures, aligning with current patient preferences. In terms of mergers, in August 2023, Medtronic acquired Mazor Robotics, enhancing its capabilities in robotic-assisted surgery, which could benefit kidney stone treatment protocols. Additionally, Boston Scientific's recent partnership with UroLift in July 2023 aims to broaden access to urinary health solutions, indirectly impacting the kidney stones segment. The overall market has experienced a shift towards more technologically-driven solutions, with companies like Stryker and Johnson and Johnson enhancing their Research and Development efforts to provide state-of-the-art solutions for kidney stone management. Joslin Diabetes Center statistics show that the incidence of kidney stones continues to rise, influencing market demand and encouraging companies to innovate in treatment approaches. ## US Kidney Stones Market Segmentation Insights ### Kidney Stones Market Type Outlook - Calcium Oxalate Stones - Uric Acid - Struvite Kidney Stones - Cystine Stones - Calcium Phosphate Stones ### Kidney Stones Market Treatment Type Outlook - Medications - Extracorporeal Shock Wave Lithotripsy - Ureteroscopy - Percutaneous Nephrolithotomy ### Kidney Stones Market Diagnosis Outlook - Ultrasound - Intravenous Pyelography - CT scan - X-Ray - Others ## Report Scope | MARKET SIZE 2024 | 567.0(USD Million) | | --- | --- | | MARKET SIZE 2025 | 594.33(USD Million) | | MARKET SIZE 2035 | 951.65(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.82% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Boston Scientific (US), Medtronic (US), Johnson & Johnson (US), C.R. Bard (US), Cook Medical (US), Olympus Corporation (JP), Stryker Corporation (US), Terumo Corporation (JP), Karl Storz (DE) | | Segments Covered | Type, Treatment Type, Diagnosis | | Key Market Opportunities | Advancements in minimally invasive treatment technologies enhance patient outcomes in the kidney stones market. | | Key Market Dynamics | Rising prevalence of kidney stones drives demand for innovative treatment options and advanced diagnostic technologies. | | Countries Covered | US | ## Frequently Asked Questions **Q: What was the overall market valuation of the US kidney stones market in 2024?** A: The overall market valuation was $567.0 Million in 2024. **Q: What is the projected market valuation for the US kidney stones market by 2035?** A: The projected valuation for 2035 is $951.65 Million. **Q: What is the expected CAGR for the US kidney stones market during the forecast period 2025 - 2035?** A: The expected CAGR for the market during this period is 4.82%. **Q: Which types of kidney stones generated the highest revenue in 2024?** A: In 2024, Calcium Oxalate Stones generated $227.0 Million, leading the market. **Q: What are the projected revenues for Ureteroscopy by 2035?** A: The projected revenue for Ureteroscopy by 2035 is $350.0 Million. **Q: Which treatment type had the highest valuation in 2024?** A: In 2024, Ureteroscopy had the highest valuation at $200.0 Million. **Q: What is the revenue range for CT Scans in the diagnosis segment by 2035?** A: The revenue range for CT Scans in the diagnosis segment is projected to be $350.0 Million by 2035. **Q: Who are the key players in the US kidney stones market?** A: Key players include Boston Scientific, Medtronic, Johnson & Johnson, and C.R. Bard. **Q: What was the revenue for Struvite Kidney Stones in 2024?** A: The revenue for Struvite Kidney Stones in 2024 was $68.0 Million. **Q: What is the projected revenue for Calcium Phosphate Stones by 2035?** A: The projected revenue for Calcium Phosphate Stones by 2035 is $186.65 Million. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-kidney-stones-market-53302*